Traws Pharma inc (TRAW) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TRAW Annual Balance Sheets →
The table below presents a historical view of Traws Pharma inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & Short-term Investments0.00
Accounts receivable3.45
Other Current Assets4.98
Prepaid Expense And Other Assets Current0.59
Total Current Assets9.02
Equipment/Property/Plant Net0.01
Intangible Assets2.44
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents3.13
Total Assets11.47
Liabilities
Accounts Payable, Current AC6.33
Accrued Liabilities, Current AC3.40
Other Liabilities, Current0.00
Total Current Liabilities9.74
Total Long-term Debt0.00
Other liabilities, Noncurrent0.04
ContractWithCustomerLiabilityNoncurrent-
Contract With Customer Liability Current-
Total Liabilities9.78
Stockholders' Equity
Common Stock Value0.15
Additional Paid In Capital Common Stock651.69
Retained Earnings / Accumulated Deficit-650.15
Accumulated Other Comprehensive Income-0.01
Defined Benefit Plan and Other0.04
Other Equity-0.01
Common Stockholder's Equity1.69
Total Stockholder's Equity1.69
Liabilities & Stockholder's Equity11.47
4 historic quarters locked

Sign in to unlock the full Traws Pharma inc balance sheet history.

About Traws Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-097261

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.